The Pituitary World News Podcast

S7E8: Pregnancy and acromegaly

A discussion of acromegaly and what to do with medical treatment during pregnancy and the options available today.

S7E7: Living with Hypopituitarism

Rachael Clare was diagnosed with a pituitary macroadenoma at age 21.  Now at 28, in a frank and revealing chat, she shares her experiences and struggles with diagnosis and living with hypopituitarism. Her blog, The Mass and Me, gives us an honest look at her story to help bring more awareness to the challenges of this disease.    

S7E6: Ten Cushing's Cases

Our section for physicians and health care professionals launches today with a podcast by Dr. Lewis Blevins that discusses ten fascinating cases of patients with hypercortisolism. We hope this section will serve as a platform to share important information, which we hope will lead to a broader understanding of pituitary disease. We invite you to comment and provide feedback to share the teaching points that this type of involvement can provide to the awareness and treatment of a disease.

Stay tuned for much more from Dr. Blevins and colleagues. We encourage you to contact us to share interesting cases and information.

S7E5: Cushing's disease and syndrome: The evolving story of hypercortisolism.

How is the emerging knowledge of hypercortisolism influencing how Cushing's disease and syndrome are understood and affecting the practice and those working on the front lines doing the work and caring for patients?  In this podcast, Michael Evans, Director, Commercial Insights, Learning and Development at Corcept Therapeutics, and Lewis Blevins, M.D., Medical Director of the Californian Center for Pituitary Disorders at UCSF and Pituitary World News Co-founder, consider the timeline and evolution of our understanding of the disease as the last ten years, has had a significant impact and brings a new set of challenges to suspect and recognize these conditions earlier.

S7E4: The critical need for early diagnosis: a chat with Dr. Javier Salvador

At Pituitary World News we are committed, some would say obsessed, with the need to reduce the time it takes to diagnose pituitary disease. This podcast offers a candid discussion about this and many issues of importance to people dealing with pituitary disease. We caught up with Spanish endocrinologist Dr. Javier Salvador, professor at the Universidad de Navarra last year in Bilbao, Spain. This is our chat. I hope you enjoy it as much as I did.

S7E3: Cortisol levels after Cushing's surgery

Today, a brief informal discussion of Cushing's disease issues from cases, articles, and experiences with his patients.

S7E2: The Road to MYCAPSSA: A Conversation with Dr. Bill Ludlam

We recently had a chance to sit down with Chiasma Inc.’s Senior VP of Clinical Development & Medical Affairs, Dr. Bill Ludlam, to discuss his career and his work in rare diseases. Dr. Ludlam played an integral role in Chiasma’s acquisition of the first and only FDA approval for oral somatostatin analog (SSA) octreotide, called MYCAPSSA. We discussed the influences that drive Chiasma as an organization and Dr. Ludlam personally, as well as the processes that contributed to the development of MYCAPSSA. Don’t miss this engaging conversation.

S7E1: A pituitary patient’s experience with COVID-19

A compelling, detailed account of a pituitary patient’s experience with COVID-19 everyone should listen.  As the virus takes hold in what is undoubtedly the worst phase of this pandemic, we urge you to follow all the guidelines provided by the health authorities:  wash your hands often, wear a mask when you are around other people, avoid crowds, and maintain the appropriate distance.

S6E21: Telemedicine and COVID-19, insights from our survey

Not surprisingly, COVID-19 appears to have significantly impacted pituitary patients' access to healthcare.  Our brief survey elicited information from respondents on their experiences and attitudes towards obtaining healthcare via telemedicine.  Dr. Blevins shares the findings in this enlightening podcast.

S6E20: During these trying times, work continues, even at a faster pace, for new drugs and therapies for pituitary patients.

From the J D Faccinetti, co-founder - We recently caught up with Crinetics Pharmaceuticals chairman Dr. Scott Struthers to discuss the latest on their new drugs currently under development. We wondered how this critically important work for pituitary patients was affected by the pandemic. Dr. Struthers gives us an "insider's view" of their work and an update on the progress in the development of these new medications for acromegaly, neuroendocrine tumors, congenital hyperinsulinism, Cushing's disease, congenital adrenal hyperplasia, and more. Don't miss this fascinating discussion.

Click here to learn more about how you may be able to participate. For more in-depth information on this subject, listen to our podcasts series on new drug development, "The Journey to a New Drug."